Qiming U.S. Healthcare Fund II, L.P. - Jun 29, 2021 Form 4 Insider Report for Elevation Oncology, Inc. (ELEV)

Role: 10%+ Owner
Signature: Qiming U.S. Healthcare Fund II, L.P., by Qiming U.S. Healthcare GP II, LLC, its General Partner
Stock symbol: ELEV
Transactions as of: Jun 29, 2021
Transactions value $: $5,000,000
Form type: 4
Date filed: 7/1/2021, 07:45 PM
Previous filing: Jun 24, 2021
Next filing: Jul 28, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELEV	Common Stock	Conversion of derivative security	$0	+1.66M		$0.00	1.66M	Jun 29, 2021	Direct	F1, F2
transaction	ELEV	Common Stock	Conversion of derivative security	$0	+401K	+24.21%	$0.00	2.06M	Jun 29, 2021	Direct	F1, F2
transaction	ELEV	Common Stock	Purchase	$5M	+313K	+15.19%	$16.00^*	2.37M	Jun 29, 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELEV	Series A Preferred Stock	Conversion of derivative security	$0	-7M	-100%	$0.00^*	0	Jun 29, 2021	Common Stock	1.66M		Direct	F1, F2
transaction	ELEV	Series B Preferred Stock	Conversion of derivative security	$0	-1.69M	-100%	$0.00^*	0	Jun 29, 2021	Common Stock	401K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date.
F2	The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming"). Qiming U.S. Healthcare GP II, LLC ("Qiming GP") is the General Partner of Qiming, and may deem beneficial ownership of shares held by Qiming, and includes Gary Rieschel, as Managing Member of Qiming GP, and Mark McDade, Co-Founder, and Partner of Qiming, that each may share voting and investment power of the shares held by Qiming.

Content

The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date.

The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming"). Qiming U.S. Healthcare GP II, LLC ("Qiming GP") is the General Partner of Qiming, and may deem beneficial ownership of shares held by Qiming, and includes Gary Rieschel, as Managing Member of Qiming GP, and Mark McDade, Co-Founder, and Partner of Qiming, that each may share voting and investment power of the shares held by Qiming.